英国心律学会共识:生命末期停用植入式心律转复除颤器电击治疗
英国心律学会发布共识指南,针对植入式心律转复除颤器(ICD)患者在生命末期可能接受多次痛苦电击或装置延迟自然死亡的风险,提出应适时与患者讨论并停用电击功能。指南涵盖装置类型、伦理法律、讨论时机与停用操作,面向非心脏科团队,以促进及时沟通和最佳实践。
要点
- ICD患者临终前若未停用电击,可能遭受多次痛苦电击或装置延迟自然死亡。
- 应适时与患者讨论停用ICD电击功能,以保障高质量终末期照护。
- 指南面向非心脏科团队,提供装置类型、伦理法律及停用操作等实用建议。
核心结论
- ICD患者临近生命末期时应有机会考虑并讨论停用电击功能,以避免痛苦电击和装置延迟自然死亡。
- 英国心律学会共识指南旨在促进专业人员与患者及时讨论并推动最佳实践。
研究设计与样本
- 英国心律学会制定的共识指南,面向所有照护ICD患者的医疗专业人员。
主要发现
- ICD植入数量增加且患者带装置生存更久,更多患者将因心衰加重、非心脏疾病或一般衰弱而预后有限。
- 若未停用ICD电击治疗,患者临终前可能接受多次痛苦电击,装置也可能延迟自然死亡。
- 非心脏科团队常照护此类患者,可能对ICD不够熟悉。
关键数值与推荐
- 指南包含不同装置类型的描述、伦理与法律方面、ICD讨论的时机与性质以及装置停用的实用建议。
临床怎么用
- 非心脏科团队应主动与ICD患者讨论停用电击功能的选项,并按照指南操作停用装置。
- 在患者临终阶段及时评估并实施ICD电击功能停用,以保障终末期照护质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Implantable cardioverter defibrillators (ICDs) are implanted in increasing numbers of patients with the aim of treating ventricular arrhythmias in high-risk patients and reducing their risk of dying. Individuals are also living longer with these devices. As a result, a greater number of patients with an ICD will deteriorate either with worsening cardiac failure, another non-cardiac condition or general frailty and will have a limited prognosis. Frequently, they will be cared for by non-cardiac teams who may be less familiar with ICDs. Therefore, to ensure the person receives high-quality end-of-life care, they should have the opportunity to consider and discuss the option to deactivate the shock function of their ICD. If the ICD shock therapy is not discontinued, there is an increased risk that, as a person reaches the last days of life, the ICD may deliver multiple, painful shocks that are distressing. There is also a risk that the device may delay the person's natural death, which the person would not have chosen if they had been given the opportunity to discuss discontinuation. The British Heart Rhythm Society has developed a practical guideline to support all healthcare professionals who are caring for patients who have an ICD. This includes descriptions of different device types, ethical and legal aspects, timing and nature of ICD discussions and practical advice regarding how the devices may be deactivated. It aims to promote awareness and timely discussion between professionals and patients and to encourage best practice.
引用
- Thomas H, Dutton A, Johnson MJ, et al. The discontinuation of implantable cardioverter defibrillator shock therapies towards the end of life: consensus guideline from the British Heart Rhythm Society. Age Ageing. 2024. PMID: 39537430. doi:10.1093/ageing/afae246
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。